Personalized Medicine Will Not Destroy Blockbuster Model – Pfizer Exec
Executive Summary
The move to personalized medicine will not put an end to the pharmaceutical blockbuster model, Pfizer Senior VP-Science & Technology Peter Corr said May 16
You may also be interested in...
Targeted Therapies Could Make Rx Companies More Credible, Lilly Exec Says
A move to more targeted therapies could improve trust of the pharmaceutical industry, Lilly New Product Planning Director Maureen Kiley told a Cambridge Healthtech Institute conference on targeted therapeutics
Targeted Therapies Could Make Rx Companies More Credible, Lilly Exec Says
A move to more targeted therapies could improve trust of the pharmaceutical industry, Lilly New Product Planning Director Maureen Kiley told a Cambridge Healthtech Institute conference on targeted therapeutics
Genetic Testing Will Contribute To Growth In Drug Spending, Medco Predicts
The growing prevalence of genetic testing as a clinical tool will drive increased drug spending and have a significant impact on medical practice, Medco predicts in its 2006 Drug Trend Report